Drug & intervention
estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG [Covaryx]
RxCUI 705920
What this record represents
SBDC · RxNormThis is an RxNorm SBDC drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
CovaryxBN · CureCurrent ID 37612
estrogens, esterified (USP) / methyltestosterone Oral Tablet [Covaryx]SBDF · CureCurrent ID 37614
estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG [Covaryx]SBDC · CureCurrent ID 37613
estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet [Covaryx]SBD · CureCurrent ID 37615
estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Covaryx]SBD · CureCurrent ID 37617
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.